Circulating vascular endothelial growth factor in patients with colorectal cancer

American Journal of Gastroenterology

Volumn 93, Issue 2, 1998, Pages 249-252

  Fujisaki, Kazuhiro ^a   Mitsuyama, Keiichi ^b   Toyonaga, Atsushi ^b   Matsuo, Katsuhiko ^b   Tanikawa, Kyuichi ^b  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; VASCULOTROPIN;

AGED; ARTICLE; CANCER STAGING; COLON ADENOMA; COLORECTAL CANCER; DISEASE ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM ADENOMA;

ADENOMA; AGED; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LYMPHOKINES; MALE; TUMOR MARKERS, BIOLOGICAL; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032008385     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00249.x     Document Type: Article

References (28)

1. 1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990;82:4-6.
2. 2. Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
3. 3. Schreiber AB, Winkler ME, Derynck R. Transforming growth factor-α: A more potent angiogenic mediator than epidermal growth factor. Science 1986;232:1250-3.
4. 4. Friedman E, Gold LI, Klimstra D, et al. High levels of TGFβ1 correlate with disease progression in human colon cancer. Gastroenterology 1995;108:A470 (abstract).
5. 5. Goldfarb M. The fibroblast growth factor family. Cell Growth Differ 1990;1:439-45.
6. 6. Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-62.
7. 7. Tischer E, Gospodarowicz D, Mitchell R, et al. Vascular endothelial growth factor: A new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 1989;165:1198-206.
8. 8. Kim KJ, Li B, Winer J, et al. Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature 1993;362:841-4.
9. 9. Asano M, Yukita A, Matsumoto T, et al. Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121. Cancer Res 1995;55:5296-301.
10. 10. Leung DW, Cachianes G, Kuang WJ, et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989;246: 1306.
11. 11. Plate KH, Breier G, Weich HA, et al. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-8.
12. 12. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993; 143:1255-62.
13. 13. Boocock CA, Charnock-Jones DS, Sharkey AM, et al. Expression of vascular endothelial growth factor and its receptors flt and kdr in ovarian carcinoma. J Natl Cancer Inst 1995;87:506-16.
14. 14. Toi M, Hoshina S, Takayanagi T, et al. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 1994;85: 1045-9.
15. 15. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptor in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993; 53:4727-35.
16. 16. Takahashi Y, Kitadai Y, Bucana CD, et al. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res 1995;55:3964-8.
17. 17. Hanatani M, Tanaka Y, Kondo S, et al. Sensitive chemiluminescence enzyme immunoassay for vascular endothelial growth factor/vascular permeability factor in human serum. Biosci Biotech Biochem 1995; 59:1958-9.
18. 18. Dukes CE, Bussey HJR. The spread of rectal cancer and its effect on prognosis. Br J Cancer 1958;12:309-20.
19. 19. Mitsuyama K, Toyonaga A, Sasaki E, et al. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994;96:432-6.
20. 20. Hirai H. A collaborative clinical study of carcinoembryonic antigen in Japan. Cancer Res 1977;37:2267-74.
21. 21. Maeda K, Chung Y-S, Ogawa Y, et al. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 1996;77:858-63.
22. 22. Robert SW, Hui Y, Mary R, et al. Regulation by vascular endothelial growth factor of human colon cancer tumorigenesis in a mouse model of experimental liver metastasis. J Clin Invest 1995;95:1789-97.
23. 23. Slentz K, Senagore A, Hibbert J, et al. Can preoperative and postoperative CEA predict survival after colon cancer resection? Am Surg 1994;60:528-31.
24. 24. Hohenberger P, Schlag PM, Gerneth T, et al. Pre-and postoperative carcinoembryonic antigen determinations in hepatic resection for colorectal metastasis. Ann Surg 1994;219:135-43
25. 25. Freeman MR, Schneck FX, Gagnon ML, et al. Peripheral blood T lymphocytes and lymphocytes infiltrating human cancers express vascular endothelial growth factor: A potential role for T cells in angiogenesis. Cancer Res 1995;55:4140-5.
26. 26. Edi B, Tiangen W, Namiki A, et al. Indirect angiogenic cytokines upregulate VEGF and bFGF expression only. Circ Res 1994;90:649-52.
27. 27. Tsushima H, Kawata S, Tamura S, et al. High levels of transforming growth factorjβ1 in patients with colorectal cancer: Association with disease progression. Gastroenterology 1996;110:375-82.
28. 28. Pertovaara L, Kaipainen A, Mustonen T, et al. Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 1994;269:6271-4.